ZIG
REGN icon

Zullo Investment Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Zullo Investment Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-121
Closed -$87.3K – 572
2022
Q4 		$87.3K Hold
121
– – 0.05% 212
2022
Q3 		$83K Buy
121
+2
+2% +$1.26K 0.05% 215
2022
Q2 		$70K Hold
119
– – 0.04% 240
2022
Q1 		$83K Buy
119
+1
+0.8% +$633 0.04% 244
2021
Q4 		$75K Buy
+118
New +$72.5K 0.04% 254

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Zullo Investment Group's REGN Position: Q1 2023 in Review

Zullo Investment Group sold out of Regeneron Pharmaceuticals (REGN) in Q1 2023, closing a stake of 121 shares — an estimated $87.3K sold.

Zullo Investment Group first reported a position in REGN in Q4 2021 and held it in 5 quarters. The position peaked at $87.3K in Q4 2022. 1,191 funds tracked by Wall St. Rank hold REGN as of Q1 2023.

  • Zullo Investment Group reported no remaining Regeneron Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Zullo Investment Group sold 121 Regeneron Pharmaceuticals shares in Q1 2023, an estimated $87.3K.
  • Zullo Investment Group first reported a position in Regeneron Pharmaceuticals in Q4 2021 and held it in 5 quarters.
  • Zullo Investment Group's Regeneron Pharmaceuticals position peaked at $87.3K in Q4 2022.
  • 1,191 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2023.

Based on Zullo Investment Group's 13F filing for Q1 2023, filed 25 Apr 2023.